Beranda › Leukemia Mieloid Akut › Texas › Fort Worth
Uji klinis Leukemia Mieloid Akut di Fort Worth, TX
4 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Fort Worth (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- Cook Children's Medical Center, Fort Worth
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Cook Children's Medical Center, Fort Worth
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Menerima pesertaFase 1
- Cook Children's Medical Center, Fort Worth
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Cook Children's Hospital, Fort Worth
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di Fort Worth
- Kanker Paru Non-Sel Kecil18 studi
- Kanker Ovarium17 studi
- Kanker Endometrium12 studi
- Kanker Payudara11 studi
- Kanker (semua jenis)9 studi
- Kanker Prostat9 studi
- Gagal Jantung7 studi
- Kanker Kolorektal7 studi
- Kanker Payudara Triple-Negatif7 studi
- Kanker Metastatik7 studi
- Kanker Ginjal (Karsinoma Sel Renal)7 studi
- Kolitis Ulseratif7 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.